Arriving in the arena of weight management management, retatrutide is a distinct strategy. Unlike many current medications, retatrutide works as a twin agonist, simultaneously engaging both GLP peptide-1 (GLP-1) and glucose-dependent insulinotropic substance (GIP) sensors. The dual engagement encourages several beneficial effects, such as enhanced